Growth Metrics

Gilead Sciences (GILD) Current Assets (2016 - 2025)

Gilead Sciences' Current Assets history spans 17 years, with the latest figure at $18.3 billion for Q4 2025.

  • For Q4 2025, Current Assets fell 4.33% year-over-year to $18.3 billion; the TTM value through Dec 2025 reached $18.3 billion, down 4.33%, while the annual FY2025 figure was $18.3 billion, 4.33% down from the prior year.
  • Current Assets reached $18.3 billion in Q4 2025 per GILD's latest filing, up from $17.9 billion in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $19.2 billion in Q4 2024 to a low of $12.3 billion in Q2 2024.
  • Average Current Assets over 5 years is $14.9 billion, with a median of $14.4 billion recorded in 2022.
  • Peak YoY movement for Current Assets: crashed 54.76% in 2021, then increased 20.94% in 2025.
  • A 5-year view of Current Assets shows it stood at $14.8 billion in 2021, then dropped by 2.23% to $14.4 billion in 2022, then increased by 11.37% to $16.1 billion in 2023, then rose by 19.2% to $19.2 billion in 2024, then dropped by 4.33% to $18.3 billion in 2025.
  • Per Business Quant, the three most recent readings for GILD's Current Assets are $18.3 billion (Q4 2025), $17.9 billion (Q3 2025), and $14.7 billion (Q2 2025).